Glycated albumin produced in diabetic hyperglycemia promotes monocyte secretion of inflammatory cytokines and bacterial adherence to epithelial cells

Journal of Periodontal Research

Volumn 50, Issue 2, 2015, Pages 197-204

  Shim, E ^a,b   Babu, J P ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Advanced glycation end products; Cytokines; Diabetes; Lipopolysaccharide; Periodontitis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AGER PROTEIN, HUMAN; CYTOKINE; GLYCOSYLATED SERUM ALBUMIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR;

ACTINOMYCES; ANTAGONISTS AND INHIBITORS; BACTERIUM ADHERENCE; BLOOD; CELL CULTURE; CELL CULTURE TECHNIQUE; CYTOLOGY; DIABETES MELLITUS; EPITHELIUM CELL; GINGIVA; HUMAN; HYPERGLYCEMIA; IMMUNOLOGY; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; PREVOTELLA; SECRETION (PROCESS);

ACTINOMYCES; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; BACTERIAL ADHESION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS; EPITHELIAL CELLS; GINGIVA; HUMANS; HYPERGLYCEMIA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MONOCYTES; PORPHYROMONAS GINGIVALIS; PREVOTELLA; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923846001     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12194     Document Type: Article

References (42)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Schmidt MI, Duncan BB, Sharrett AR et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-1652.
3. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79:49-57.
4. Brownlee M. The pathological implications of protein glycation. Clin Invest Med 1995;18:275-281.
5. Luger A, Schernthaner G, Urbanski A, Luger TA. Cytokine production in patients with newly diagnosed insulin-dependent (type I) diabetes mellitus. Eur J Clin Invest 1988;18:233-236.
6. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y. Periodontal disease as part of the insulin resistance syndrome in diabetic patients. J Int Acad Periodontol 2005;7:16-20.
7. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004;95:233-238.
8. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol 2005;25:1401-1407.
9. Zhang L, Zalewski A, Liu Y et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003;108:472-478.
10. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev 2001;17:436-443.
11. Hasegawa G, Hunter AJ, Charonis AS. Matrix nonenzymatic glycosylation leads to altered cellular phenotype and intracellular tyrosine phosphorylation. J Biol Chem 1995;270:3278-3283.
12. Hong SB, Lee KW, Handa JT, Joo CK. Effect of advanced glycation end products on lens epithelial cells in vitro. Biochem Biophys Res Commun 2000-2005;275:53-59.
13. Bendayan M. Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes. Kidney Int 1998;54:438-447.
14. Nakayama M, Kawaguchi Y, Yamada K et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182-186.
15. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol 2001;6:113-118.
16. Hou FF, Miyata T, Boyce J et al. Beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 2001;59:990-1002.
17. Molvig J, Baek L, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988;27:705-716.
18. Salvi GE, Yalda B, Collins JG et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
19. Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998;3:40-50.
20. Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 2004;123:87-92.
21. Sekizuka K, Tomino Y, Sei C et al. Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 1994;68:284-285.
22. Albandar JM. Global risk factors and risk indicators for periodontal disease. Periodontology 2002;29:177-206.
23. Hugoson A, Thorstensson H, Falk J, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215-223.
24. Emrich LJ, Schlossman M, Genco RJ. Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol 1991;62:123-130.
25. Westphal O, Jann K. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. In: Whistler RL, ed. Methods in Carbohydrate Chemistry. New York: Academic Press Inc., 1965:83-91.
26. Obayashi T, Tamura H, Tanaka S et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985;149:55-65.
27. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:531-536.
28. Grossi SG, Zambon JJ, Ho AW et al. Asssessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
29. Schmidt AM, Weidman E, Lalla E et al. Advanced glycation endproducts induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodont Res 1996;31:508-515.
30. Hunt J, Smith C, Wolff S. Auto oxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990;30:1420-1424.
31. Chang P-C, Chien L-Y, Yeo J-F et al. Progression of periodontal destruction and the roles of advanced glycation end-products in experimental diabetes. J Periodontol 2013;84:379-388.
32. Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 2001;6:125-137.
33. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527-1534.
34. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: a multi-ligand unveiling novel insights in health and disease. Curr Med Chem 2010;17:2232-2252.
35. Collison KS, Parhar RS, Saleh SS et al. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol 2002;71:433-444.
36. Chang P-C, Chien L-Y, Kuo Y-P, Hsiao J-K. Glycated matrix up-regulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide. J Periodont Res 2013;48:184-193.
37. Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008;15:135-141.
38. Pacios S, Kang J, Galicia J et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012;26:1423-1430.
39. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89:1349-1363.
40. Vaahtoniemi L, Raisanen S, Stenfors L-E. Attachement of bacteria to oral epithelial cells in vivo: a possible correlation to gingival health status. J Periodont Res 1993;28:308-311.
41. Chen P, Cisar JO, Hess S, Ho JTC, Leung KP. Amended description of the genes for synthesis of Actinomyces naeslundii T14V type 1 fimbriae and associated adhesin. Infect Immun 2007;75:4181-4185.
42. Tang GY, Yip HK, Samaranayake LP, Chan KY, Luo G, Fang HH. Direct detection of cell surface interactive forces of sessile, fimbriated and non-fimbriated Actinomyces supp. using atomic force microscopy. Arch Oral Biol 2004;49:727-738.